Shield To Acquire Echodyne In Transaction Valued at $5.3 Bln; Raises 2.5 Bln At $28.8 Bln Valuation

By Reuters News

- Blackstone Inc. BX.N:

  • SHIELD TO ACQUIRE ECHODYNE IN A TRANSACTION VALUED AT $5.3 BILLION AND RAISE $2.5 BILLION AT A $28.8 BILLION VALUATION

  • SHIELD: RAISING $2.5 BILLION TO SUPPORT TRANSACTION, INCLUDING $1 BILLION IN SERIES H FUNDING

  • SHIELD: $2.5 BILLION RAISE INCLUDES A $1 BILLION STRUCTURED EQUITY INVESTMENT FROM FUNDS MANAGED BY BLACKSTONE

  • SHIELD: $2.5 BILLION RAISE INCLUDES $500 MILLION IN DEBT FINANCING LED BY JPMORGAN CHASE BANK, N.A. AS SOLE ARRANGER

  • SHIELD : SERIES H FUNDING CO-LED BY DISRUPTIVE AND INNOVATION X CAPITAL

  • SHIELD: OF $5.3 BILLION TRANSACTION VALUE, UP TO AN ADDITIONAL $500 MILLION IS CONTINGENT ON ECHODYNE MEETING AGREED PERFORMANCE TARGETS

Further company coverage: BX.N

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.